Tekla Capital Management LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2021$3,096,000
-14.2%
180,4380.0%0.10%
-18.5%
Q1 2021$3,609,000
+17.7%
180,4380.0%0.12%
+14.8%
Q4 2020$3,067,000
-29.7%
180,438
-31.4%
0.11%
-34.1%
Q3 2020$4,364,000
-28.4%
263,0790.0%0.16%
-29.3%
Q2 2020$6,093,000
+29.7%
263,0790.0%0.23%
+9.4%
Q1 2020$4,696,000
-23.3%
263,079
-7.3%
0.21%
-8.6%
Q4 2019$6,123,000
+18.5%
283,6790.0%0.23%
+3.1%
Q3 2019$5,167,000
-48.8%
283,6790.0%0.22%
-45.4%
Q2 2019$10,093,000
+5.9%
283,6790.0%0.41%
+6.5%
Q1 2019$9,532,000
+207.3%
283,679
+200.6%
0.39%
+191.0%
Q4 2018$3,102,000
-76.1%
94,384
-55.6%
0.13%
-71.7%
Q3 2018$12,952,000
+40.5%
212,469
+12.6%
0.47%
+34.3%
Q2 2018$9,218,000
-30.3%
188,769
+51.6%
0.35%
-32.0%
Q1 2018$13,231,000
+63.7%
124,517
-81.4%
0.52%
+36.2%
Q3 2014$8,082,000669,6000.38%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 598,400$10,083,0003.98%
Opus Point Partners Management, LLC 348,583$5,874,0003.88%
Camber Capital Management LP 3,500,000$58,975,0003.81%
1492 Capital Management LLC 180,601$3,043,0002.21%
Virtus ETF Advisers LLC 38,260$645,0001.77%
Cormorant Asset Management, LP 765,156$12,893,0001.54%
Rhenman & Partners Asset Management AB 581,000$9,790,0001.48%
Granahan Investment Management 2,082,155$35,084,0001.21%
BRIDGER MANAGEMENT, LLC 1,563,862$26,351,0000.87%
RICE HALL JAMES & ASSOCIATES, LLC 899,531$15,157,0000.87%
View complete list of NEKTAR THERAPEUTICS shareholders